UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
기사
(전체 333건)
제목보기
제목보기
제목+내용
기사보기
Oscotech wins exception policy for continued R&D for new drugs
The stock market regulat...
Jeong Sae-im
|
2019-06-25 14:11
기사보기
Despite regulator’s ruling delay, Kolon TissueGene likely to be reviewed for delisting
Jeong Sae-im
|
2019-06-20 14:20
기사보기
294 shareholders file suit against Kolon TissueGene for damage compensation
Kolon TissueGene said in...
Jeong Sae-im
|
2019-06-14 10:51
기사보기
Celltrion unveils P3 trial results for rheumatoid biosimilar in Europe
Celltrion has presented ...
Lee Han-soo
|
2019-06-13 16:10
기사보기
Kolon TissueGene CEO resigns
Kolon TissueGene, a subsidiary of Kolon Life...
Jeong Sae-im
|
2019-06-07 15:35
기사보기
[ASCO 2019] ‘Ontruzant demonstrates equal quality to original drug’
CHICAGO, Ill. -- Samsung...
Lee Han-soo, KBR correspondent
|
2019-06-04 14:17
기사보기
Kolon’s minority shareholders demand over ₩25 billion in damage
Minority shareholders of...
Jeong Sae-im
|
2019-06-03 14:53
기사보기
Invossa inventor sold Kolon shares at highest value
Former Kolon TissueGene ...
Jeong Sae-im
|
2019-06-03 14:52
기사보기
Until when will Kolon keep lying about Invossa?
Kolon Life Science’s “ex...
Jeong Sae-im
|
2019-05-31 14:59
기사보기
Samsung BioLogics agrees to manufacture CytoDyn’s HIV drug
Samsung BioLogics said i...
Jeong Sae-im
|
2019-05-31 14:59
기사보기
Announcement of Invossa license revocation was ‘procedural breach’: Kolon
The government’s recent ...
Jeong Sae-im
|
2019-05-30 13:28
기사보기
‘MDM2 gene’ may be associated with hyperprogression after immunotherapy
Oncology researchers aro...
Kim Yun-mi
|
2019-05-29 12:35
-
이전
11
12
13
14
15
16
17
18
19
20
다음
-
Back to Top